Olivia Arballo, DO in Fort Campbell, KY - Medicare Dermatology

Olivia Arballo, DO is a medicare enrolled "Dermatology" physician in Fort Campbell, Kentucky. Her current practice location is 650 Joel Dr, Fort Campbell, Kentucky. You can reach out to her office (for appointments etc.) via phone at (270) 798-8345.

Olivia Arballo is licensed to practice in Tennessee (license number 4164) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1184084089.

Contact Information

	Olivia Arballo, DO
	650 Joel Dr, Fort Campbell, KY 42223-5318
	(270) 798-8345
	Not Available

Physician's Profile

Full Name	Olivia Arballo
Gender	Female
Speciality	Dermatology
Location	650 Joel Dr, Fort Campbell, Kentucky
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1184084089
Provider Enumeration Date: 03/04/2016
Last Update Date: 05/11/2023

Medicare PECOS Information:

PECOS PAC ID: 7911399027
Enrollment ID: I20220124001218

Medical Identifiers

Medical identifiers for Olivia Arballo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1184084089	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	4164 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Olivia Arballo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Olivia Arballo, DO Blanchfield Army Community Hospital, 650 Joel Drive, Fort Campbell, KY 42223 Ph: () -	Olivia Arballo, DO 650 Joel Dr, Fort Campbell, KY 42223-5318 Ph: (270) 798-8345

News Archive

Researchers develop new technique to automatically control anaesthesia during surgical operations

A team of researchers from the Canary Islands has developed a technique for automatically controlling anaesthesia during surgical operations. The new system detects the hypnotic state of the patient at all times and supplies the most appropriate dose of anaesthetic.

Black men of all income levels experience higher levels of discrimination than white counterparts

A woman grips her purse tightly as you approach. A store manager follows you because you look "suspicious." You enter a high-end restaurant, and the staff assume you're applying for a job. You're called on in work meetings only when they're talking about diversity.

New Jersey's paid family leave program needs adequate information and better outreach

New Jersey parents say that inadequate information and outreach, a lack of employer support, and a confusing application process discourage their participation in the state's landmark paid family leave program, according to new research from the National Center for Children in Poverty at Columbia University's Mailman School of Public Health.

New discovery on how botulism paralyzes nerve cells

New structures of a botulism toxin interacting with a mimic of the nerve-cell protein it destroys suggest new ways to block this often-fatal interaction. Indeed, the mimic molecules have such high affinity for the toxin and bind to it so tightly that they themselves could possibly serve as anti-toxin drugs with further modification, the researchers said.

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to treat Dry Age-Related Macular Degeneration (AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

Olivia Arballo, DO - Medicare Dermatology in Fort Campbell, KY